Ā | n | ICCa | 95% CIb |
---|---|---|---|
EORTC QLQ-C30: | Ā | Ā | Ā |
Functional scales: | Ā | Ā | Ā |
Physical function | 34 | 0.87 | 0.76-0.93 |
Role function | 33 | 0.80 | 0.64-0.90 |
Emotional function | 34 | 0.73 | 0.52-0.85 |
Cognitive function | 34 | 0.79 | 0.62-0.89 |
Social function | 34 | 0.84 | 0.71-0.92 |
Global QoL/GHS | 34 | 0.33 | -0.01-0.59 |
Symptom scales: | Ā | Ā | Ā |
Fatigue | 34 | 0.82 | 0.67-0.90 |
Pain | 34 | 0.74 | 0.54-0.86 |
Nausea and vomiting | 34 | 0.43 | 0.11-0.67 |
Single items c : | Ā | Ā | Ā |
Dyspnoea | 34 | 0.63 | 0.37-0.79 |
Sleep disturbance | 34 | 0.76 | 0.58-0.87 |
Appetite loss | 34 | 0.74 | 0.54-0.86 |
Diarrhoea | 34 | 0.33 | -0.003-0.60 |
Constipation | 34 | 0.54 | 0.25-0.74 |
Financial impact | 34 | 0.75 | 0.56-0.87 |
EORTC QLQ-CR38: | Ā | Ā | Ā |
Functional scales: | Ā | Ā | Ā |
Body image | 32 | 0.71 | 0.49-0.85 |
Future perspective | 32 | 0.76 | 0.56-0.87 |
Sexual functioning | 31 | 0.82 | 0.66-0.91 |
Sexual enjoyment | 11 | NA | NA |
Symptom scales: | Ā | Ā | Ā |
Radiation-induced effects micturition | 32 | 0.67 | 0.43-0.82 |
Chemotherapy side effects | 32 | 0.70 | 0.47-0.84 |
General gastrointestinal symptoms | 32 | 0.65 | 0.39-0.81 |
Defecation problems | 26 | NA | NA |
Stoma-related problems | 6 | NA | NA |
Sexual dysfunction of men | 14 | NA | NA |
Sexual dysfunction of women | 3 | NA | NA |
Weight loss | 32 | 0.36 | 0.02-0.63 |
FACT-C: | Ā | Ā | Ā |
Physical Well-Being | 34 | 0.76 | 0.57-0.87 |
Social/Family Well-Being | 33 | 0.51 | 0.23-0.73 |
Emotional Well-Being | 34 | 0.79 | 0.62-0.89 |
Functional Well-Being | 34 | 0.73 | 0.52-0.85 |
Colorectal Cancer Specific | 34 | 0.77 | 0.59-0.90 |
FACT-C total score | 34 | 0.75 | 0.55-0.87 |
Trial Outcome Index-Colorectal | 34 | 0.82 | 0.66-0.90 |